OC-0317: Risk factors for persistent late fatigue after radiochemotherapy in cervical cancer (EMBRACE study). (November 2020) - Smet, S.; Tanderup, K.; Nout, R.; Jürgenliemk-Schulz, I.; Spampinato, S.; Chargari, C.; Lindegaard, J.; Mahantshetty, U.; Strudza, A.; Schmid, M.; Hoskin, P.; Segedin, B.; et al.